Group 1 - The core viewpoint of the news is that Intell Group's stock has shown positive performance with a 2.03% increase on January 13, reaching a price of 13.07 yuan per share, with a total market capitalization of 7.228 billion yuan [1] - As of January 13, 2023, the stock has increased by 2.51% year-to-date, 1.16% over the last five trading days, 13.75% over the last 20 days, and 15.56% over the last 60 days [1] - The company primarily engages in the wholesale and retail of pharmaceuticals and medical devices, with 93.76% of its revenue coming from pharmaceutical sales, 5.67% from medical device sales, and 0.56% from other sources [1] Group 2 - As of December 31, 2023, the number of shareholders for Intell Group increased by 5.35% to 27,000, with an average of 12,707 circulating shares per person, reflecting a 0.94% increase [2] - For the period from January to September 2025, Intell Group reported a revenue of 24.963 billion yuan, a year-on-year increase of 0.75%, while the net profit attributable to shareholders decreased by 9.15% to 323 million yuan [2] - The company has distributed a total of 5.32 billion yuan in dividends since its A-share listing, with 4.23 billion yuan distributed over the past three years [3]
英特集团涨2.03%,成交额1.39亿元,主力资金净流入335.90万元